Discontinuation report BRAVELLE
Report ID | 90130 |
Drug Identification Number | 02268140 |
Brand name | BRAVELLE |
Common or Proper name | UROFOLLITROPIN FOR INJECTION, PURIFIED |
Company Name | FERRING INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | |
Strength(s) | |
Dosage form(s) | |
Route of administration | |
Packaging size | 75 IU |
ATC code | |
ATC description | |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-07-18 |
Remaining supply date | 2019-07-18 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | BRAVELLE is discontinued. Alternate products are available by Ferring such as REKOVELLE (follitropin delta for injection, 33.3 mcg/mL rFSH). Please contact your healthcare professional. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-07-29 | French | Compare |
v3 | 2019-07-29 | English | Compare |
v2 | 2019-07-29 | English | Compare |
v1 | 2019-07-29 | English | Compare |
Showing 1 to 4 of 4